GlassScriptPhysician profile
Kimberly E Stephens
NPI 1295626083
$667.65
in general payments reported to CMS, 2019-2025
16 companies · $668 in 2025
The $668 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $132.07 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $128.92 | 2025 | Airsupra, Farxiga |
| Abbvie INC. | $75.07 | 2025 | |
| Novartis Pharmaceuticals Corporation | $39.22 | 2025 | |
| Lilly USA, LLC | $36.24 | 2025 | Kisunla, Zepbound, Mounjaro |
| Corcept Therapeutics | $34.40 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.39 | 2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.48 | 2025 | Jardiance |
| Amgen INC. | $32.37 | 2025 | Otezla, Repatha, Krystexxa |
| Otsuka America Pharmaceutical, INC. | $20.40 | 2025 | Rexulti |
| Novo Nordisk INC | $18.59 | 2025 | Ozempic |
| Phathom Pharmaceuticals, INC. | $17.28 | 2025 | Voquezna |
| Lundbeck LLC | $17.24 | 2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $16.99 | 2025 | Zoryve |
| Sumitomo Pharma America, INC. | $16.02 | 2025 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.